C. Andrew Boswell

4.6k total citations
56 papers, 3.4k citations indexed

About

C. Andrew Boswell is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, C. Andrew Boswell has authored 56 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Radiology, Nuclear Medicine and Imaging, 27 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in C. Andrew Boswell's work include Monoclonal and Polyclonal Antibodies Research (28 papers), Radiopharmaceutical Chemistry and Applications (18 papers) and HER2/EGFR in Cancer Research (13 papers). C. Andrew Boswell is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (28 papers), Radiopharmaceutical Chemistry and Applications (18 papers) and HER2/EGFR in Cancer Research (13 papers). C. Andrew Boswell collaborates with scholars based in United States, France and Belgium. C. Andrew Boswell's co-authors include Martin W. Brechbiel, Leslie A. Khawli, Paul J. Fielder, Carolyn J. Anderson, Gary R. Weisman, Edward H. Wong, Daniela Bumbaca, Xiankai Sun, Weijun Niu and Arnold L. Rheingold and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and The Journal of Experimental Medicine.

In The Last Decade

C. Andrew Boswell

54 papers receiving 3.2k citations

Peers

Countries citing papers authored by C. Andrew Boswell

Since Specialization

Citations

This map shows the geographic impact of C. Andrew Boswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Andrew Boswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Andrew Boswell more than expected).

Fields of papers citing papers by C. Andrew Boswell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Andrew Boswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Andrew Boswell. The network helps show where C. Andrew Boswell may publish in the future.

Co-authorship network of co-authors of C. Andrew Boswell

This figure shows the co-authorship network connecting the top 25 collaborators of C. Andrew Boswell. A scholar is included among the top collaborators of C. Andrew Boswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Andrew Boswell. C. Andrew Boswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Measurement of specific and nonspecific tissue uptake of antibodies in tumor by SPECT imaging and nonlinear compartmental modeling 2025 ·EJNMMI Research ·Nicholas S. Cho, Jason Ho, Geoffrey Del Rosario, Shang‐Fan Yu, Gregory Z. Ferl, C. Andrew Boswell	0
2	Imaging Reveals Importance of Shape and Flexibility for Glomerular Filtration of Biologics 2021 ·Molecular Cancer Therapeutics ·(unknown), Alberto Estevez, Gregory Z. Ferl, Danielle Mandikian, (unknown), (unknown), Simon P. Williams, Amrita V. Kamath, James T. Koerber, C. Andrew Boswell	8
3	Effect of Modulating FcRn Binding on Direct and Pretargeted Tumor Uptake of Full-length Antibodies 2020 ·Molecular Cancer Therapeutics ·Lidia Nazarova, (unknown), Danielle Mandikian, Gregory Z. Ferl, James T. Koerber, C. Davies, Sheila Ulufatu, Jason Ho, Jeffrey Lau, Shang‐Fan Yu, James A. Ernst, Jack Sadowsky, C. Andrew Boswell	11
4	Balancing the Affinity and Pharmacokinetics of Antibodies by Modulating the Size of Charge Patches on Complementarity-Determining Regions 2020 ·Journal of Pharmaceutical Sciences ·Yue Sun, Hao Cai, Zhilan Hu, C. Andrew Boswell, (unknown), Charlene Li, (unknown), Amy Shen, (unknown), (unknown), Amrita V. Kamath, Guoying Jiang	4
5	Hyaluronic Acid–Antibody Fragment Bioconjugates for Extended Ocular Pharmacokinetics 2019 ·Bioconjugate Chemistry ·Amin Famili, Susan Crowell, Kelly M. Loyet, Danielle Mandikian, C. Andrew Boswell, David Cain, Joyce Chan, Laëtitia Comps‐Agrar, Amrita V. Kamath, Karthikan Rajagopal	14
6	Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model 2018 ·Molecular Cancer Therapeutics ·Danielle Mandikian, (unknown), (unknown), Ji Li, Jeffrey Eastham‐Anderson, Dionysos Slaga, Jason Ho, Maria Hristopoulos, Robyn Clark, Klára Tótpál, Kedan Lin, Sean B. Joseph, Mark S. Dennis, Saileta Prabhu, Teemu T. Junttila, C. Andrew Boswell	112
7	Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging 2018 ·mAbs ·Danielle Mandikian, (unknown), Pragya Adhikari, (unknown), Lidia Nazarova, Gabriel Fung, Isabel Figueroa, Gregory Z. Ferl, Sheila Ulufatu, Jason Ho, (unknown), Jeffrey Lau, Shang‐Fan Yu, Saileta Prabhu, Jack Sadowsky, C. Andrew Boswell	9
8	Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies 2015 ·Neuron ·Nga Bien‐Ly, C. Andrew Boswell, Surinder Jeet, Thomas G. Beach, Kwame Hoyte, Wilman Luk, (unknown), Sheila Ulufatu, Oded Foreman, Yanmei Lu, Jason DeVoss, Marcel van der Brug, Ryan J. Watts	150
9	Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics 2015 ·Journal of Biological Chemistry ·Daniela Bumbaca Yadav, Vikas Sharma, C. Andrew Boswell, Isidro Hötzel, Devin B. Tesar, Yonglei Shang, Yong Ying, Saloumeh K Fischer, Jane L. Grogan, Eugene Y. Chiang, (unknown), Sheila Ulufatu, Leslie A. Khawli, Saileta Prabhu, Sean B. Joseph, Robert F. Kelley	63
10	Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge 2014 ·mAbs ·Bing Li, Devin B. Tesar, C. Andrew Boswell, (unknown), Anne Wong, Jianhua Zhang, Y. Gloria Meng, Charles Eigenbrot, Homer Pantua, (unknown), Sharookh B. Kapadia, Rong Deng, Robert F. Kelley	99
11	Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice 2014 ·mAbs ·Amrita V. Kamath, Victor Yip, Priyanka Gupta, C. Andrew Boswell, Daniela Bumbaca, Peter C. Haughney, (unknown), Siao Ping Tsai, Glenn Pacheco, Sarajane Ross, Minhong Yan, Lisa A. Damico‐Beyer, Leslie A. Khawli, Ben‐Quan Shen	15
12	Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants 2014 ·The Journal of Experimental Medicine ·Nga Bien‐Ly, Yang Yu, Daniela Bumbaca, Justin Elstrott, C. Andrew Boswell, Yin Zhang, Wilman Luk, Yanmei Lu, Mark S. Dennis, Robby M. Weimer, Inhee Chung, Ryan J. Watts	244
13	Differential Effects of Predosing on Tumor and Tissue Uptake of an¹¹¹In-Labeled Anti-TENB2 Antibody–Drug Conjugate 2012 ·Journal of Nuclear Medicine ·C. Andrew Boswell, Eduardo E. Mundo, Crystal Zhang, (unknown), Shang‐Fan Yu, Jennifer A. Lacap, Weiguang Mao, Katherine R. Kozak, (unknown), Paul Polakis, Leslie A. Khawli, Kedan Lin	42
14	Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics 2012 ·The AAPS Journal ·Daniela Bumbaca, C. Andrew Boswell, Paul J. Fielder, Leslie A. Khawli	91
15	Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow 2011 ·PLoS ONE ·C. Andrew Boswell, Gregory Z. Ferl, Eduardo E. Mundo, Daniela Bumbaca, Michelle Schweiger, Frank‐Peter Theil, Paul J. Fielder, Leslie A. Khawli	28
16	A novel side-bridged hybrid phosphonate/acetate pendant cyclam: Synthesis, characterization, and 64Cu small animal PET imaging 2008 ·Bioorganic & Medicinal Chemistry ·C. Andrew Boswell, Celeste A.S. Regino, Kwamena E. Baidoo, Karen Wong, Diane E. Milenic, James A. Kelley, Christopher C. Lai, Martin W. Brechbiel	28
17	Investigation of copper–azamacrocyclic complexes by high‐performance liquid chromatography 2005 ·Biomedical Chromatography ·(unknown), C. Andrew Boswell, Edward H. Wong, Gary R. Weisman, Carolyn J. Anderson, Sterling A. Tomellini	4
18	Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS 2005 ·Nuclear Medicine and Biology ·C. Andrew Boswell, Paul McQuade, Gary R. Weisman, Edward H. Wong, Carolyn J. Anderson	38
19	Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice 2003 ·Vaccine ·Frank A. Scappaticci, (unknown), C. Andrew Boswell, Jason S. Lewis, Garry P. Nolan	11
20	Conjugation of Monoclonal Antibodies with TETA Using Activated Esters: Biological Comparison of ⁶⁴ Cu-TETA-1A3 with ⁶⁴ Cu-BAT-2IT-1A3 2001 ·Cancer Biotherapy and Radiopharmaceuticals ·Michael R. Lewis, C. Andrew Boswell, Richard Laforest, Thomas Buettner, Dan Ye, Judith M. Connett, Carolyn J. Anderson	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact